UK Infected Blood Inquiry publishes its final report

On 20 May 2024 the UK Infected Blood Inquiry published its final report on decades of harm through blood products — a warning for blood safety everywhere, including Nepal.

What the inquiry found

The UK Infected Blood Inquiry described a calamity in which thousands of people were infected with HIV and hepatitis through blood and blood products, including people with haemophilia treated with factor concentrate from pooled plasma.

The report criticised decades of delay, missing records, and failure to switch to safer products when evidence existed. Compensation and accountability processes continue in the United Kingdom; that is not Nepal’s legal process.

Why NHS shares this news

Nepal Hemophilia Society publishes inquiry updates because the lesson crosses borders: screened donations, virus-inactivated products, and batch records for every patient are not optional extras.

Families here may ask whether past products were safe. Honest answers require hospital records and testing pathways, not rumours on social media.

What Nepal should demand

Factor assays before treatment plans. Virus-inactivated concentrate when procurement allows. Written product name and batch for every infusion. National blood policy that learns from international scandals before harm happens.

Humanitarian aid from the World Federation of Hemophilia helps some patients but is not a substitute for a government supply system with safety rules.

If you are worried about past treatment

Go to your treatment centre or a hospital that can test for HIV and hepatitis B and C. Take old discharge papers if you have them.

NHS can point you to support pages on this website and advocate for clearer national testing policy. The office cannot interpret your personal test results by email.

This page is general information from Nepal Hemophilia Society. It is not a diagnosis or a treatment plan. A bleed, a head injury, or bleeding after an accident needs urgent hospital care. Ask your treatment centre before you change any treatment.